Search All UT System Experts

Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study

Ioana R. Preston, Richard N. Channick, Kelly Chin, Lilla Di Scala, Harrison W. Farber, Sean Gaine, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Irene M. Lang, Vallerie V. McLaughlin, Ralph Preiss, Ge´rald Simonneau, Olivier Sitbon, Victor F. Tapson, Lewis J. Rubin

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI<sub>2</sub>) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study'. Together they form a unique fingerprint.

Medicine & Life Sciences